NCT04454177View on ClinicalTrials.gov

SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

July 1, 2031

Conditions
Aortic StenosisValvular Heart DiseaseTranscatheter Aortic Valve Replacement
Interventions
DEVICE

HUAWEI watch

HUAWEI Watch will be assigned to patients within 24 hours before TAVR. HUAWEI Watch GT series can continuously monitor and record multiple biometric parameters heart rate, step counts, sleep cycles and can detect and record the pulse oxygen saturation, as well as analyze QRS complexes and P waves after triggering.

Trial Locations (1)

310000

RECRUITING

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER